Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma

This study is ongoing, but not recruiting participants.

Study NCT00089115 Information provided by National Cancer Institute (NCI)

First Received: August 4, 2004 Last Updated: October 14, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Lymphoma

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

rituximab
sargramostim

Additional drug interventions recognized in this trial

More general drug interventions related to this trial

Sponsors listed in this trial

Favrille